



Obituary for Paul Bacon
Buckley, Christopher; Gordon, Caroline; Isenberg, David ; Snaith, Michael ; Scott, David G. I.;
Luqmani, Raashid; Moots, Robert; Carruthers, David; Southwood, Taunton; Young, Stephen;




Other (please specify with Rights Statement)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Buckley, C, Gordon, C, Isenberg, D, Snaith, M, Scott, DGI, Luqmani, R, Moots, R, Carruthers, D, Southwood, T,
Young, S, Kitas, G & Raza, K 2018, 'Obituary for Paul Bacon', Rheumatology, vol. 57, no. 5, pp. 943-945.
https://doi.org/10.1093/rheumatology/key030
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
This is a pre-copyedited, author-produced PDF of an article accepted for publication in Rheumatology following peer review. The version of
record Christopher D Buckley, Caroline Gordon, David Isenberg, Michael Snaith, David G I Scott, Raashid Luqmani, Robert Moots, David
Carruthers, Taunton Southwood, Stephen Young, George Kitas, Karim Raza; Obituary for Paul Bacon, Rheumatology, Volume 57, Issue 5,
1 May 2018, Pages 943–945, https://doi.org/10.1093/rheumatology/key030 is available online at: 10.1093/rheumatology/key030
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
Obituary for Paul Bacon 
Christopher D Buckley, Caroline Gordon,  David Isenberg,  Michael Snaith, David GI Scott, 
Raashid Luqmani, Robert Moots, David Carruthers, Taunton Southwood, Stephen Young, 
George Kitas, Karim Raza 
 
Paul Bacon, Emeritus Professor of Rheumatology and the first Professor of Rheumatology in 
Birmingham UK, died peacefully on Friday 12th January 2018 after a short illness. Positive 
and organised until the end, he was able to say “goodbye” to his family and friends who 
came to visit him and his wife Jean over the Christmas period at their retirement home in 
Lancashire.  
 
Paul Bacon was a pioneering rheumatologist whose seminal work provided robust 
instruments to measure outcomes in patients with systemic rheumatic diseases. It would 
not be an overstatement to say that the concept of quantifying disease activity, damage and 
functional outcome, embedded in the indices that Paul helped develop, laid the foundations 
for the subsequent successful assessment of biological therapy that has transformed our 
discipline. Rheumatology stopped being a Cinderella speciality in the 1990’s with the 
introduction of biologic drugs and the fact that we could measure their benefits robustly. 
Without such measurements many of the treatments now being used to treat lupus and 
vasculitis would never have been approved. The legacy of this legend of British 
Rheumatology is that he forced a sceptical discipline to measure and record change and not 
rely just on subjective clinical opinion.  
 
Brought up at a Quaker school (Leighton Park) in Reading, he went up to Cambridge to read 
medicine and finished his clinical training as a medical student at St Bartholomew’s Hospital 
(Barts) in London. He said he was “the black sheep of the family” as he eschewed two 
generations of family tradition in actuarial studies to pursue a career in medicine. After 
graduation he became interested in Cardiology and was fortunate to be a junior physician in 
the cardiology unit at Barts that introduced cardiac catheterization to the UK. He often 
mentioned that observing the precision with which cardiologists measured disease activity 
led him to want to do the same in Rheumatology, which until the 1980’s lacked such precise 
tools. From 1965 to 1968 Paul was a Research Fellow at the newly established Kennedy 
Institute in London and with an Arthritis Research Council travelling fellowship visited Carl 
Pearson’s group in UCLA in 1971. Carl also taught him to measure; this time pathology 
scores in animal models of arthritis. His time in the USA also gave him a taste for American 
dress and barbeques (do you remember the boot lace ties and cowboy shirts?) 
 
Paul returned to the UK in 1972 to become consultant rheumatologist at the Royal National 
Hospital for Rheumatic Diseases in Bath and Southmead Hospital in Bristol. He was one of 
the first to set up specialist clinics and with research fellows such as David G.I. Scott he 
established a systemic vasculitis clinic in order to make comparisons between the 
pathologies that drive different forms of vasculitis (for example Rheumatoid Vasculitis 
compared to ANCA or lupus-associated vasculitis). David remembers being “run ragged 
round the hospitals” by Paul in order to collect and curate the patient cohorts. Those who 
worked with Paul invariably recall his enthusiasm, boundless energy and his ability to 
somehow make you say “yes” when you really wanted to say “no”. 
 
Following the endowment of a chair in Rheumatology in Birmingham by the Arthritis 
Research Council (the predecessor of Arthritis Research UK), Paul was appointed as its 
foundation chair in 1981.  The inspired use of the endowment, with further core funding by 
the ARC in the 1980’s, was vital in allowing Rheumatology in Birmingham to develop. Along 
with many other UK units, Paul would not have been able to achieve his vision for 
Birmingham without such support. As David Scott recollects: “With the endowment, Paul 
was able to draw up a very detailed ten year plan for the expansion of Rheumatology in the 
Midlands and for the development of a first class combined clinical and laboratory unit. That 
he achieved all the goals he had set, in much less than ten years, including a dramatic 
expansion of Birmingham-linked clinical posts in the region, was characteristic of his vision 
and energy”. It was even more remarkable as his predecessor (Clifford Hawkins) had been 
the only academically active Rheumatologist in the West Midlands at the time.   
 
Paul was one of the first to use the principle of the physician’s intention to treat to help 
derive outcome measures. Two decades later this same principle was used in the 2010 
EULAR/ACR classification of Rheumatoid Arthritis, based on the intention to use 
methotrexate. In 1984 he founded the British Isles Lupus Assessment Group (BILAG) with 
Mike Snaith, Peter Maddison, David Isenberg and Asad Zoma. A picture of the “BILAG 
bench” where the idea of BILAG was born in Paul’s garden in Birmingham was beautifully 
captured during the BILAG 21st celebrations in 2005 (see picture: Paul’s apron shows that 
he was Head of Barbeque!). In 1988 the BILAG group, together with colleagues from 
Toronto (notably Dafna Gladman and Murray Urowitz) and Boston (Matt Liang) met in 
Birmingham at a meeting funded by NATO and organised by Paul. Its mission was to try and 
bring some harmony to the thorny issue of how best to assess disease activity in SLE. This 
group became established in 1991 as the Systemic Lupus Erythematosus Collaborating 
Clinics (SLICC) group and continues to meet twice a year. 
 
By the early 1990’s Paul had transformed the rheumatology department in Birmingham into 
a world class unit. He had come back from a sabbatical at the NIH in Bethesda in 1988 full of 
energy and re-inoculated with the American 'can-do' spirit. With characteristic energy he 
supported the development of the Birmingham Vasculitis Activity Score, published in 1994 
with Raashid Luqmani and Robert Moots playing key roles. His consummate skills as a 
collaborator further revealed themselves. With Loic Guillevin, Wolfgang Gross, Gene Hunder 
and Cees Kallenberg and with Caroline Savage and Jo Adu in Birmingham, he drove 
comparisons between renal and rheumatological vasculitis for the first time. Much against 
perceived wisdom at the time, he and Raashid found that the mortality and morbidity in 
patients with airways vasculitis was similar to those with renal vasculitis. As in many areas 
Paul was the first to break down boundaries; this time across medical specialities.  He 
pioneered the development of Paediatric Rheumatology in Birmingham, appointing Taunton 
Southwood as professor. He was one of the first to appreciate the need for transitional care 
as children with rheumatic diseases became adults and needed specialist clinical care. 
 
During the late 1980’s Paul began setting up specialist clinics, often an uphill struggle. With 
Eddie Tunn and Margaret Farr he established one of the first early arthritis clinics in the UK, 
based on his experiences in Bath. He set up a specialist clinic in scleroderma which Tom 
Sheeran and Mark Pugh ran for some time. Deborah Symmons and then Caroline Gordon 
established the Birmingham Lupus Cohort which, with Caroline’s expert leadership, has 
become the Jewel in the Birmingham crown. He supported the development of specialist 
clinics in Bechet’s and Sjogrens Syndromes and was delighted in his retirement to see the 
establishment of National Centres in these diseases involve colleagues in Birmingham such 
as Deva Situnayake (Bechets), Emma Derrett-Smith (Scleroderma) and Simon Bowman 
(Sjogrens).  
 
Paul was not just interested in clinical indices for systemic rheumatic diseases. He also had a 
deep interest in the pathogenic mechanisms that underpin rheumatic diseases including 
Rheumatoid Arthritis and the Spondyloarthropathies. He was extremely supportive of 
discovery science within his unit. Soon after his move to Birmingham, laboratory studies on 
the processes driving joint damage in Rheumatoid Arthritis were established with a focus on 
oxidative damage with David Blake and immune cell dysfunction with Steve Young and Mike 
Salmon.  During the 1990’s he supported and encouraged the careers of Paul Emery 
(rheumatoid arthritis) and Hill Gaston (spondyloarthropathies) who moved to chairs in 
Leeds and Cambridge respectively. He also took pride in supporting and mentoring the 
career of non-clinical scientists such as Steve Young and Mike Salmon. Mike subsequently 
took over as Head of Department from 2002 until his cruelly premature retirement due to ill 
health in 2008. Mike made important scientific discoveries on naïve and memory T cells in 
health and disease and developed strategic links between the Birmingham Rheumatology 
unit and other renowned immunology departments, such as that in Birmingham and the 
Royal Free in London.  Mike and Paul were instrumental in supporting and developing the 
careers of Chris Buckley and Karim Raza, who were both subsequently appointed to the 
Arthritis Research UK (ARUK) Chair in 2002 and 2017. In particular Paul took great delight in 
supporting the careers of those who came to train in the UK and was especially proud of the 
achievements of George Kitas in researching the cardiovascular comorbidities of 
Rheumatoid Arthritis.  Paul also supported the development of metabolomics by facilitating 
the location of the first high field NMR spectrometer in Birmingham within the Department. 
Many scientists completed PhDs in the department during this time and they owe much to 
Paul’s support and encouragement. In particular Darrell Pilling, Jane Goodall and Dagmar 
Scheel-Toellner were appointed as ARUK Fellows during this golden era for Paul.      
 
Above all Paul was an enthusiast. He always took an interest in trainees, never smothered 
them, yet could be infuriatingly stubborn. His opinion was hard to change. He disliked U 
turns. Whilst this led him to remarkable achievements in the clinical arena, it got him into 
trouble with discovery scientists who wanted him to alter and retest his 'hypotheses' when 
there was overwhelming evidence against his view. In later years he was persuaded that 
changing your mind could actually be a sign of great strength. Many of those who worked 
with him remember Paul as a dogma-busting, disruptive force with a keen and astute mind 
and a first rate chairman of any panel he led. Many British rheumatologists trained with Paul 
during his 21 years as ARC Chair in Birmingham. We think he trained more Professors of 
Rheumatology than any other academic in the UK (16 and counting). 
 
Paul’s appointment in Birmingham coincided with the 'birth' of rheumatology as a medical 
sub-speciality. He made sure that all members of his unit took part in teaching medical 
students. Paul’s patients with vasculitis captured the imagination of students. He used this 
to encourage some of the brightest medical students in Birmingham to consider 
Rheumatology as a career. He also persuaded a small but significant number of students to 
study for PhDs during their undergraduate training (in effect an MD PhD programme). David 
Carruthers, and his colleague Maggie Allen became hooked and, as Paul’s last Clinical 
lecturers before he retired, they were extraordinary proselytizers for Rheumatology 
amongst medical students in Birmingham. Paul was delighted to learn that David Carruthers 
(now Medical Director at Sandwell and West Birmingham NHS Trust) was appointed 
Professor of Rheumatology based largely on his inspirational teaching to undergraduate 
medical students.   
 
Like all of us, Paul was paradoxical. He could be puritanical in his zeal for a particular project 
or cause, to the exclusion of all else around him; yet we remember him as a thoughtful, 
supportive and caring mentor, physician and friend. For many he acted as a wise councillor 
and confidant, especially when the emotional pressures of working in medicine and 
research affected family life. He did so willingly, at times involving considerable self-
sacrifice, and always with enormous compassion. He was always engaging, always 
encouraging, always enabling and supporting trainees (and not just those in his own unit) to 
find a niche and become a specialist in it. He had time for trainees and genuinely took 
pleasure in seeing them shine. Paul believed that research mattered and saved lives. It’s a 
shame that he was not academically active in the UK during the last decade of his life when 
the National Institute for Health Research (NIHR) would have been a wonderful vehicle to 
help him deliver his vision of research for the benefit of patients.  
 
Paul never really retired after he stepped down from the ARC Chair in 2002, much to his 
wife Jean’s dismay! He took on new projects: developing and delivering a disease activity 
index for Takayasu’s arteritis, overseeing the Birmingham Arthritis Resource Centre (BARC) 
and for five years chairing the ARUK fellowship committee. But it was his links to India that 
really drove him in retirement. He was almost evangelical in his passion for the 
development of the Indian Takayasu Activity Score. As the disease is more common in Asia 
he achieved this with the help of colleagues in India such as Rohini Handa, Ramnath Misra 
Debasish Danda and Dr K.M. Mahendranath. In Indian Rheumatology circles Paul is seen as a 
guru. While pride may prevent his national colleagues from admitting it directly, we suspect 
quite a few British rheumatologists think he is too! 
 
We will all remember Paul in different ways. He published over 380 papers, which have 
been cited over 20,000 times. But it’s neither for his seminal science nor his legendry indices 
that Paul will be most remembered. As his close friend Mike Snaith has so astutely noted it’s 
“Paul’s Pause” that we will remember him by. Mike describes this pause as “the hesitant, 
almost pernickety, form of words before his opinion was given, question put, or conclusion 
drawn”. David Scott adds “the pause almost invariably included a slight but very deliberate 
and audible clearing of the throat”.   Paul’s pause was not part of his stellar curriculum vitae, 
but a little quirk that we know many will remember as they think fondly of Paul. 
